Ophthalmology
Vyzulta Samples for Healthcare Providers
Explore medication sample resources and treatment access support for clinicians prescribing Vyzulta® (latanoprostene bunod ophthalmic solution 0.024%).
Vyzulta® (latanoprostene bunod ophthalmic solution) is a prescription eye drop indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is administered once daily in the evening to the affected eye and may be prescribed to help protect against vision loss associated with elevated eye pressure. Vyzulta® combines prostaglandin analog activity with nitric oxide-mediated effects.
Built to help reduce friction around treatment access & patient care.
Request Vyzulta® (latanoprostene bunod ophthalmic solution 0.024%) sample support and treatment access assistance through DocUpdate Concierge.
Request Samples Through DocUpdate
DocUpdate provides free HIPAA-compliant mobile tools that move care forward.
Frequently Asked Questions About Vyzulta Samples
Healthcare providers can download the DocUpdate app and submit a request through Concierge for medication sample and treatment access support.
Vyzulta is a prescription ophthalmic solution used to lower intraocular pressure.
Vyzulta may be prescribed for reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
DocUpdate is designed for licensed healthcare providers with an active NPI number, including physicians, nurse practitioners, and physician assistants.
No. DocUpdate does not dispense medications or provide direct medication fulfillment. The platform helps healthcare providers navigate medication sample support and treatment access resources through Concierge.
Yes. DocUpdate provides free HIPAA-compliant tools and support resources for healthcare providers.